Overview

Update
Total Equity Funding
$1M in 2 Rounds from 1 Investor
Most Recent Funding
$1M Venture on January 1, 2007
Headquarters:
San Diego, CA
Description:
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.
Categories:
Health Care
Website:
http://www.regenemed.com

Company Details

Update

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.

Funding Rounds (2) - $1M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2007$1M / Venture1
Jun, 2005undisclosed amount / Venture1

Investors (1)

InvestorRound(s)Partner(s)
Venture-
Venture-

Offices/Locations (1)

Update
  • Office

    9855 Towne Centre Drive

    Suite 200

    San Diego, CA 92121

    USA

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add News

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos